Richard A. Flavell, Ph.D., FRS

Yale University
New Haven, CT

Dr. Richard A. Flavell is the Sterling Professor of Immunobiology at Yale University, and a Howard Hughes Medical Institute investigator.

Dr. Flavell is one of the co-discoverers of the intron segments in genes. He also revealed the link between DNA methylation and gene expression, helped define the transcription factors that regulate CD4+ T cell development, and identified the roles of several innate immune receptors. In recognition, Dr. Flavell received the 2012 William B. Coley Award for Distinguished Research in Basic Immunology, and has also been elected to the National Academy of Sciences and the Royal Society of London. His current work focuses on topics including T cell differentiation, inflammasomes, and intestinal microbiota.

Dr. Flavell has been a member of CRI’s Scientific Advisory Council since 2013.

Our research uses transgenic and gene-targeted mice to study Innate and Adaptive immunity, T cell tolerance and activation in immunity and autoimmunity, apoptosis, and regulation of T cell differentiation.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.